Bal Pharma Limited

Web: balpharma.com NSE: BALPHARMA BSE: 524824 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

88 0(0%)

Volume

49k as on 23, Jun

Open

High

Low

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

57/100

Growth Score

50/100

Valuation Score

50/100

Momentum Score

25/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

140

No. of Shares

1.59

P/E

19.13

P/B

1.89

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

9.89

ROCE

Profit Growth

Listing Date

08-May-06

Promoter Holding

50.87%

FII Holding

0.15%

DII Holding

Price Chart

Price Performance

1 Week4%

1 Month5%

3 Months30%

6 Months21%

1 Year21%

YTD21%

Moving Average

5 Day SMA87

10 Day SMA87

20 Day SMA88

30 Day SMA86

50 Day SMA82

61 Day SMA80

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	90	88	89	91
Resistance 2	89	87	89	90
Resistance 1	88	87	88	89
Pivot Point	87	87	87	88
Support 1	86	87	87	87
Support 2	85	87	86	86
Support 3	84	87	85	85

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 50.87%	(0.01) 50.87%	(0.01) 50.87%	(0.01) 50.87%	(0.01) 50.87%	(0.01) 50.87%	(0.01) 50.87%	(-0.41) 50.87%	(0.01) 51.24%	(0.01) 51.24%	(-0.41) 51.24%	(0.01) 51.61%	(0.01) 51.61%	(0.01) 51.61%	(-0.41) 51.61%	(0.01) 52.00%	(2.41) 52.00%	(0.01) 49.57%	(2.71) 49.57%	(0.01) 46.87%
FIIs	(0.01) 0.15%	(0.01) 0.14%	(-0.11) 0.14%	(0.11) 0.23%	(0.01) 0.15%	(0.01) 0.14%	(0.01) 0.14%	(0.01) 0.13%	(0.01) 0.13%	(0.01) 0.13%	(0.01) 0.13%	(0.01) 0.14%	(0.01) 0.17%	(0.01) 0.17%	(0.01) 0.18%	(-0.11) 0.20%	(0.01) 0.30%	(0.01) 0.31%	(0.21) 0.31%	(0.01) 0.15%
Public	48.99%	49.01%	49.01%	48.91%	48.99%	49.01%	49.00%	49.01%	48.63%	48.64%	48.64%	48.25%	48.23%	48.23%	48.21%	47.80%	47.71%	50.12%	50.12%	52.98%
No. of Shareholders	14,974	15,214	15,520	15,774	15,826	15,723	15,667	16,007	15,014	14,772	15,060	15,529	15,869	16,029	16,466	16,170	16,317	16,223	16,049	16,319

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	88.62	84.08	87.69	74.02	65.87	81.88	73.15	73.69	74.36	94.63	81.66	92.54	70.39	82.45	76.62	75.31	69.84	74.05	69.17	67.17	70.83
Sales Growth % (YoY)	34.5%	2.7%	19.9%	0.4%	-11.4%	-13.5%	-10.4%	-20.4%	5.6%	14.8%	6.6%	22.9%	0.8%	11.3%	10.8%	12.1%	-1.4%	4.6%	9.7%	4%	35.9%
Sales Growth % (QoQ)	5.4%	-4.1%	18.5%	12.4%	-19.6%	11.9%	-0.7%	-0.9%	-21.4%	15.9%	-11.8%	31.5%	-14.6%	7.6%	1.7%	7.8%	-5.7%	7.1%	3%	-5.2%	-
Expenses	80.67	73.5	78.15	68.29	59.81	74.24	65.4	66	67.89	85.03	73.87	84.84	63.95	74.29	70.47	69.53	64.8	70.6	62.95	60.84	63.35
Operating Profit	7.95	10.58	9.54	5.73	6.06	7.64	7.75	7.69	6.47	9.6	7.79	7.7	6.44	8.16	6.15	5.78	5.04	3.45	6.22	6.33	7.48
OPM %	8.97	12.58	10.88	7.74	9.2	9.33	10.59	10.44	8.7	10.14	9.54	8.32	9.15	9.9	8.03	7.67	7.22	4.66	8.99	9.42	10.56
Other Income	0.44	-0.24	0.33	1.12	0.72	1.08	0.51	-0.2	0.82	2.45	0.1	0.14	0.16	0.19	0.46	0.05	0.24	3.7	0.75	0.56	0.14
Interest	4.47	4.06	4.85	3.86	4.05	3.95	5.01	3.65	4.24	4.14	3.66	3.82	3.64	3.85	3.11	2.86	2.37	2.45	2.36	2.63	2.97
Depreciation	2.78	3.06	3.23	2.27	2.52	2.18	2.69	2.48	2.43	2.16	2.96	2.42	2.53	2.09	2.45	2.37	2.23	2.42	2.21	2.21	2.19
Profit before tax	1.14	3.22	1.79	0.72	0.21	2.59	0.56	1.36	0.62	5.75	1.27	1.6	0.43	2.41	1.05	0.6	0.68	2.28	2.4	2.05	2.46
Tax %	0	-12.11	0	0	0	-108.88	7.14	23.53	58.06	3.65	33.07	39.38	79.07	32.78	43.81	78.33	58.82	3.95	80.42	31.71	32.93
Net Profit	1.13	3.6	1.79	0.72	0.21	5.41	0.52	1.04	0.26	5.53	0.85	0.97	0.09	1.62	0.59	0.12	0.28	2.19	0.48	1.39	1.65
Net Profit Growth % (QoQ)	-68.6%	101.1%	148.6%	242.9%	-96.1%	940.4%	-50%	300%	-95.3%	550.6%	-12.4%	977.8%	-94.4%	174.6%	391.7%	-57.1%	-87.2%	356.2%	-65.5%	-15.8%	-
Net Profit Growth % (YoY)	438.1%	-33.5%	244.2%	-30.8%	-19.2%	-2.2%	-38.8%	7.2%	188.9%	241.4%	44.1%	708.3%	-67.9%	-26%	22.9%	-91.4%	-83%	-	-	-	-
TTM Net Profit	7.24	6.32	8.13	6.86	7.18	7.23	7.35	7.68	7.61	7.44	3.53	3.27	2.42	2.61	3.18	3.07	4.34	5.71	3.52	3.04	0
EPS in Rs	0.7	2.25	1.12	0.45	0.13	3.41	0.3	0.65	0.16	3.46	0.56	0.61	0.05	1.02	0.36	0.07	0.18	1.33	0.43	0.93	1.09

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2011
Sales	312	303	339	304	281	251	171	225	211	229	198	187	179	114
Sales Growth %	2.8%	-10.6%	11.5%	8.2%	12.2%	46.4%	-24%	6.4%	-7.6%	15.4%	6%	4.6%	-	7.6%
Expenses	280	273	308	279	257	226	166	207	194	214	183	170	161	104
Operating Profit	32	30	31	25	24	25	5	18	17	15	15	17	18	10
OPM %	10	10	9	8	9	10	2.9	8	8	6	7	9	10	9
Other Income	2	2	3	1	5	1	2	1	2	3	1	1	1	1
Interest	17	17	15	12	11	12	13	13	9	8	6	7	7	7
Depreciation	11	10	10	9	9	10	8	6	7	6	7	7	5	3
Profit before tax	6	5	9	5	9	4	-14	0	3	3	3	5	7	1
Tax %	-7	-41	18	45	38	-15	-5	-1175	87	114	90	25	23	60
Net Profit	6	7	7	3	6	5	-13	2	0	0	1	4	5	0
Net Profit Growth %	-14.3%	-	133.3%	-50%	20%	138.5%	-750%	-	-	-100%	-75%	-20%	-	-
EPS in Rs	3.94	4.53	4.68	1.64	3.78	3.2	-8.62	2.67	1.96	1.24	1.1	2.82	4.56	0.39
Dividend Payout %	30	26	26	61	26	31	0	37	51	81	91	35	22	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2011
Cash from Operating Activity	30	20	23	-2	27	22	23	8	1	6	-19	15	13	5
Cash from Investing Activity	-21	-15	-19	-22	-9	-6	-5	-8	-4	-8	-14	-5	-7	-2
Cash from Financing Activity	-10	-8	-1	24	-17	-17	-20	0	4	-6	32	-7	-8	-2
Net Cash Flow	0	-2	3	0	0	0	-2	0	1	-8	-1	2	-2	1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2011
Equity Capital	16	16	16	16	16	16	15	15	14	14	14	14	13	13	11	10
Reserves	66	62	62	53	56	48	44	39	38	52	51	48	42	42	39	26
Borrowings	160	155	150	155	140	131	104	110	118	124	110	93	89	49	51	58
Other Liabilities	134	116	108	116	108	116	98	76	68	71	86	78	67	59	54	41
Total Liabilities	376	349	336	340	320	311	261	240	238	261	260	233	211	164	155	135
Fixed Assets	94	92	87	79	80	76	67	69	71	70	71	60	56	52	55	48
CWIP	7	3	3	2	0	0	2	0	3	4	0	2	4	1	0	0
Investments	2	0	2	11	7	0	0	0	0	0	0	0	0	0	0	0
Other Assets	272	253	244	248	233	235	192	172	164	187	188	172	151	111	99	87
Total Assets	376	349	336	340	320	311	261	240	238	261	260	233	211	164	155	135

Delivery

Delivery Data: BALPHARMA

#	Date	76 23% 94	Value (Cr)	Q/T 62	Del 56	Del 1
1	4-Sep	88	0	41	84	0
2	3-Sep	88	0	94	54	0
3	2-Sep	86	0	59	45	0
4	1-Sep	85	0	52	60	0
5	31-Aug	85	0	57	74	0
6	28-Aug	85	0	44	86	0
7	27-Aug	85	0	33	87	0
8	26-Aug	84	0	56	72	0
9	25-Aug	85	0	31	72	0
10	24-Aug	85	0	26	66	0
11	21-Aug	86	0	81	80	0
12	20-Aug	87	0	36	65	0
13	19-Aug	85	0	17	83	0
14	18-Aug	85	0	21	63	0
15	17-Aug	85	0	37	69	0
16	14-Aug	87	0	37	68	0
17	13-Aug	88	0	29	58	0
18	12-Aug	90	0	54	63	0
19	11-Aug	87	0	42	65	0
20	10-Aug	91	0	36	62	0
21	7-Aug	89	0	18	69	0
22	6-Aug	87	0	17	58	0
23	5-Aug	89	0	35	58	0
24	4-Aug	88	0	54	79	0
25	3-Aug	89	0	43	65	0
26	31-Jul	88	0	54	64	0
27	30-Jul	88	0	47	71	0
28	29-Jul	88	0	49	51	0
29	28-Jul	87	0	29	59	0
30	27-Jul	89	1	78	51	1
31	24-Jul	87	0	106	70	0
32	23-Jul	88	0	41	51	0
33	22-Jul	88	0	54	80	0
34	21-Jul	89	2	75	64	1
35	20-Jul	91	1	59	62	1
36	17-Jul	87	0	54	76	0
37	16-Jul	87	0	43	48	0
38	15-Jul	88	1	46	55	0
39	14-Jul	91	5	72	24	1
40	13-Jul	79	0	23	64	0
41	10-Jul	79	0	54	83	0
42	9-Jul	78	0	46	83	0
43	8-Jul	77	0	43	69	0
44	7-Jul	79	0	46	69	0
45	6-Jul	77	0	23	50	0
46	3-Jul	78	0	48	79	0
47	2-Jul	78	0	39	67	0
48	1-Jul	80	0	25	61	0
49	30-Jun	80	0	50	60	0
50	29-Jun	79	1	36	50	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	140c	96L	0.68
03-Sep	141c	6c	4.19
01-Sep	135c	96L	0.70
31-Aug	136c	53L	0.39
26-Aug	135c	13L	0.09
25-Aug	136c	16L	0.12
24-Aug	135c	2c	1.54
21-Aug	137c	2c	1.40
19-Aug	136c	57L	0.42
18-Aug	136c	80L	0.59
17-Aug	135c	4c	2.56
14-Aug	139c	1c	0.75
13-Aug	140c	5c	3.35
12-Aug	145c	10L	0.07
11-Aug	145c	0	0
10-Aug	145c	5c	3.81
06-Aug	140c	2c	1.28
04-Aug	141c	1c	0.79
31-Jul	140c	16L	0.11
30-Jul	140c	1c	0.89
29-Jul	142c	2c	1.42
28-Jul	140c	2c	1.42
27-Jul	142c	0	0

Stock Checklist

Price is above from 52 week high low average: 71%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView